Ipsong is committed to improving people's lives and health. Our 5,700 employees around the world work to address unmet disease treatment needs to improve the quality of life for patients and caregivers. Among the world's leading pharmaceutical companies specializing in oncology research, Ipson is conquering cancers that need to be treated urgently.

With over 25 years of research, development and business experience in the field of neuroscience, Ipson continues to work to improve the health of patients suffering from debilitating neurological diseases.

Ipson is committed to providing innovative treatment options for patients with rare diseases. By focusing on these rare diseases, we have brought about substantial change in certain areas where treatment needs are not met.